Crossref journal-article
American Society for Microbiology
Journal of Virology (235)
Abstract

ABSTRACT We have investigated whether the identity of the coreceptor (CCR5, CXCR4, or both) used by primary human immunodeficiency virus type 1 (HIV-1) isolates to enter CD4 + cells influences the sensitivity of these isolates to neutralization by monoclonal antibodies and CD4-based agents. Coreceptor usage was not an important determinant of neutralization titer for primary isolates in peripheral blood mononuclear cells. We also studied whether dualtropic primary isolates (able to use both CCR5 and CXCR4) were differentially sensitive to neutralization by the same antibodies when entering U87MG-CD4 cells stably expressing either CCR5 or CXCR4. Again, we found that the coreceptor used by a virus did not greatly affect its neutralization sensitivity. Similar results were obtained for CCR5- or CXCR4-expressing HOS cell lines engineered to express green fluorescent protein as a reporter of HIV-1 entry. Neutralizing antibodies are therefore unlikely to be the major selection pressure which drives the phenotypic evolution (change in coreceptor usage) of HIV-1 that can occur in vivo. In addition, the increase in neutralization sensitivity found when primary isolates adapt to growth in transformed cell lines in vitro has little to do with alterations in coreceptor usage.

Bibliography

Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., & Moore, J. P. (1998). Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage. Journal of Virology, 72(3), 1876–1885.

Authors 9
  1. Alexandra Trkola (first)
  2. Tom Ketas (additional)
  3. Vineet N. KewalRamani (additional)
  4. Fred Endorf (additional)
  5. James M. Binley (additional)
  6. Hermann Katinger (additional)
  7. Jim Robinson (additional)
  8. Dan R. Littman (additional)
  9. John P. Moore (additional)
References 107 Referenced 135
  1. 10.1128/jvi.59.2.284-291.1986
  2. 10.1128/jvi.69.2.1001-1012.1995
  3. 10.1097/00002030-199507000-00029
  4. 10.1126/science.272.5270.1955
  5. 10.1089/aid.1995.11.533
  6. 10.1089/aid.1996.12.1247
  7. 10.1128/jvi.68.7.4572-4579.1994
  8. 10.1038/382829a0
  9. Burton D. R. and D. Montefiori. 1997. The antibody response in HIV-1 infection. AIDS 11 (Suppl. A) : 587–598.
  10. 10.1089/aid.1996.12.173
  11. 10.1128/jvi.66.11.6547-6554.1992
  12. 10.1016/S0092-8674(00)81313-6
  13. 10.1126/science.270.5243.1811
  14. 10.1038/nm1196-1244
  15. 10.1126/science.7824947
  16. 10.1128/jvi.66.12.7517-7521.1992
  17. 10.1128/jvi.68.7.4400-4408.1994
  18. 10.1084/jem.185.4.621
  19. 10.1128/jvi.69.3.1493-1499.1995
  20. 10.1128/jvi.69.3.1810-1818.1995
  21. 10.1073/pnas.87.17.6574
  22. 10.1128/jvi.66.11.6777-6780.1992
  23. 10.1038/381661a0
  24. 10.1038/40894
  25. 10.1038/385495a0
  26. 10.1016/S0092-8674(00)81314-8
  27. 10.1097/00042560-199612010-00002
  28. 10.1038/381667a0
  29. 10.1086/516443
  30. 10.1084/jem.186.3.405
  31. 10.1038/384529a0
  32. 10.1126/science.272.5263.872
  33. 10.1006/viro.1994.1534
  34. 10.1089/aid.1996.12.1585
  35. 10.1128/jvi.66.5.3183-3187.1992
  36. 10.1006/viro.1996.0225
  37. 10.1073/pnas.94.9.4653
  38. 10.1128/jvi.69.8.4628-4632.1995
  39. 10.1128/jvi.66.12.7538-7542.1992
  40. 10.1128/jvi.69.1.523-527.1995
  41. 10.1016/S0021-9258(17)46662-2
  42. 10.1128/jvi.71.9.6296-6304.1997
  43. 10.1128/jvi.65.1.489-493.1991
  44. 10.1128/jvi.69.10.6342-6351.1995
  45. 10.1128/jvi.70.6.3589-3598.1996
  46. 10.1093/infdis/170.6.1367
  47. 10.1128/jvi.70.9.6136-6142.1996
  48. KewalRamani V. N. and D. R. Littman. Unpublished data.
  49. 10.1128/jvi.66.4.2232-2239.1992
  50. 10.1128/jvi.70.6.3668-3677.1996
  51. 10.7326/0003-4819-118-9-199305010-00004
  52. 10.1093/infdis/173.2.349
  53. 10.1128/jvi.71.2.873-882.1997
  54. 10.1128/JVI.72.3.2491-2495.1998
  55. 10.1084/jem.185.11.2015
  56. 10.1128/jvi.69.5.3167-3170.1995
  57. 10.1128/jvi.67.9.5623-5634.1993
  58. 10.1074/jbc.271.32.19084
  59. Montefiori D. C. Personal communication.
  60. 10.1128/JVI.72.3.1886-1893.1998
  61. 10.1089/aid.1993.9.529
  62. 10.1128/jvi.69.1.101-109.1995
  63. Moore J. P. and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9 (Suppl. A) : S117–S136.
  64. 10.1128/jvi.68.12.8350-8364.1994
  65. 10.1128/jvi.66.1.235-243.1992
  66. Moore J. P. and P. L. Nara. 1991. The role of the V3 domain of gp120 in HIV infection. AIDS 5 (Suppl. 2) : S21–S33. (10.1097/00002030-199101001-00004)
  67. 10.1128/jvi.69.1.122-130.1995
  68. 10.1089/aid.1993.9.1185
  69. 10.1016/S0021-9258(18)53154-9
  70. 10.1128/jvi.68.6.4031-4034.1994
  71. 10.1038/382833a0
  72. 10.1038/348069a0
  73. 10.1097/00002030-199509050-00003
  74. 10.1089/aid.1995.11.335
  75. 10.1016/0042-6822(91)90537-L
  76. 10.1128/jvi.71.2.883-890.1997
  77. 10.1093/infdis/169.5.968
  78. 10.1128/jvi.71.6.4847-4851.1997
  79. Saag M. S. S. M. Hammer and J. M. A. Lange. 1994. Pathogenicity and diversity of HIV and implications for clinical management: a review. J. Acquired Immune Defic. Syndr. 7 (Suppl. 2) : S2–S11.
  80. 10.1084/jem.182.1.185
  81. 10.1128/jvi.68.3.1342-1349.1994
  82. 10.1006/viro.1993.1637
  83. 10.1128/jvi.66.3.1354-1360.1992
  84. 10.1099/0022-1317-76-7-1665
  85. 10.1093/infdis/173.6.1485
  86. 10.1128/jvi.69.7.4453-4462.1995
  87. 10.1038/349167a0
  88. 10.1089/aid.1994.10.1679
  89. 10.1073/pnas.91.4.1214
  90. 10.1128/jvi.70.12.8355-8360.1996
  91. 10.1093/infdis/169.3.491
  92. 10.1128/jvi.69.10.6191-6198.1995
  93. 10.1128/jvi.62.6.2026-2032.1988
  94. 10.1089/aid.1996.12.191
  95. 10.1038/384184a0
  96. 10.1128/jvi.70.2.1100-1108.1996
  97. 10.1128/jvi.69.11.6609-6617.1995
  98. 10.1073/pnas.89.4.1335
  99. 10.1006/viro.1997.8606
  100. 10.1002/jlb.59.1.53
  101. 10.1128/jvi.68.2.1029-1039.1994
  102. 10.1093/infdis/173.4.877
  103. 10.1128/jvi.69.1.39-48.1995
  104. 10.1038/384179a0
  105. 10.1084/jem.185.9.1681
  106. 10.1128/jvi.70.6.3724-3733.1996
  107. 10.1126/science.8356453
Dates
Type When
Created 5 years, 8 months ago (Dec. 31, 2019, 1:08 p.m.)
Deposited 3 years, 6 months ago (March 4, 2022, 9:47 p.m.)
Indexed 4 months, 4 weeks ago (April 8, 2025, 5:42 p.m.)
Issued 27 years, 6 months ago (March 1, 1998)
Published 27 years, 6 months ago (March 1, 1998)
Published Print 27 years, 6 months ago (March 1, 1998)
Funders 0

None

@article{Trkola_1998, title={Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage}, volume={72}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.72.3.1876-1885.1998}, DOI={10.1128/jvi.72.3.1876-1885.1998}, number={3}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Trkola, Alexandra and Ketas, Tom and KewalRamani, Vineet N. and Endorf, Fred and Binley, James M. and Katinger, Hermann and Robinson, Jim and Littman, Dan R. and Moore, John P.}, year={1998}, month=mar, pages={1876–1885} }